Translational AI and Computational Tools for Ophthalmic Disease

Dear Colleagues,

Over the past several years, there have been rapid advancements in machine/deep learning and artificial intelligence (AI). These advancements have had a large impact across many fields of study, including medicine. Given the data-rich nature of modern ophthalmic care, which makes use of not only patient information and clinical tests, but also extensive imaging and functional testing, this field is especially amenable to AI and other computational approaches. Indeed, much work has been carried out to apply AI-based techniques to ophthalmic care and has even resulted in the first FDA-approved autonomous AI diagnostic system in any field of medicine (LumineticsCore by Digital Diagnostics, formerly IDx-DR). However, despite the large body of work applying AI techniques to ophthalmology, relatively little has been translated into clinical settings so far. This Special Issue focuses on the application of AI and other computational tools in building translational tools that address pressing needs in ophthalmic care. Topics of interest include (but are not limited to) work in developing and/or evaluating AI tools to address screening and diagnosis of ophthalmic diseases, predicting disease progression, forecasting the need for interventions, and clinical decision support for disease management. Work across all aspects of ophthalmic care is relevant and the focus should be on translation into clinical settings to improve care.

Dr. Mark Christopher
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.